Endocrine · 2019 · 63 citations · 23 references
MedicineOncologyPharmacologyImmunotherapyMolecular OncologyNeoplasiaCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsTargeted Cancer TherapyTargeted TherapyThyroid CancerPd-l1 BlockadeProgrammed Cell Death Ligand 1 InhibitionProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 InhibitionProgrammed Death-ligand 1 InhibitorsProgrammed Death-ligand 1 SignalingProgrammed Death-ligand 1 Targeting
23
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.5K citations · Full text
Janis M. Taube, Robert A. Anders, Geoffrey D. Young et al. · Science Translational Medicine · 2012 · 2.1K citations
Life Sciences, Immunology, Oncology +14
Guidelines for the welfare and use of animals in cancer research
Paul Workman, Eric O. Aboagye, Frances R. Balkwill et al. · British Journal of Cancer · 2010 · 1.4K citations · Full text
Medicine, Animal Sciences, Oncology +17